Sosei Heptares’ $2.6 Billion Collaboration With Neurocrine Biosciences Inc

Gowling WLG’s advised Sosei Heptares on the deal.Sosei Heptares on its collaboration with San Diego based Neurocrine Biosciences Inc to develop novel muscarinic receptor agonist compounds,…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Giulia Di Palma

Author: Giulia Di Palma

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here